GLP-1 drugs are increasingly popular in the U.S., with 11% of adults using them for weight loss. Nestlé is actively pursuing the market for products that meet the nutritional challenges faced by GLP-1 users. In 2024, they launched a GLP-1 nutrition platform offering guidance and products aimed at muscle preservation and gut health, leveraging brands like Garden of Life and Boost.
As competition grows, Big Food and health companies are adapting their strategies, viewing the need for companion nutrition products as an opportunity rather than a threat to sales. Nestlé’s strategy reflects a broader industry trend where major companies are entering the GLP-1 space, increasing competition for supplements that were initially first to cater to these consumer needs.
Market experts believe the incorporation of GLP-1-related nutrition could evolve into a mature ecosystem, signaling interest from diverse sectors including food, supplements, and pharmaceuticals. Products that uniquely address the nutrient intake challenges associated with appetite suppression from GLP-1 medication are viewed as essential, especially as users may consume less protein.
However, significant challenges remain. While some markets may benefit, others like collagen for skin health may be based on misleading marketing claims. Experts stress the importance of developing formulations that truly meet the nutritional needs of GLP-1 users, rather than merely relabeling existing products.
As demand for holistic wellness grows, companies are encouraged to rethink how they formulate products to address the specific requirements of GLP-1 consumers, suggesting that true innovation will be key to success in this emerging market.
